Biosynex SA (EPA:ALBIO)
0.9500
-0.0900 (-8.65%)
At close: Jan 28, 2026
Biosynex Revenue
Biosynex had revenue of 50.53M EUR in the half year ending June 30, 2025, with 18.46% growth. This brings the company's revenue in the last twelve months to 97.95M, down -5.87% year-over-year. In the year 2024, Biosynex had annual revenue of 101.17M with 8.81% growth.
Revenue (ttm)
97.95M
Revenue Growth
-5.87%
P/S Ratio
0.20
Revenue / Employee
215.76K
Employees
476
Market Cap
19.50M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 101.17M | 8.19M | 8.81% |
| Dec 31, 2023 | 92.98M | -103.61M | -52.70% |
| Dec 31, 2022 | 196.59M | -185.95M | -48.61% |
| Dec 31, 2021 | 382.53M | 228.64M | 148.57% |
| Dec 31, 2020 | 153.90M | 118.72M | 337.54% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Diagnostic Medical Systems | 49.47M |
| Median Technologies | 23.38M |
| Novacyt | 22.69M |
| Bluelinea Société Anonyme | 11.68M |
| Implanet | 11.10M |
| Mauna Kea Technologies | 8.18M |
| Carmat | 7.34M |
| Affluent Medical | 5.27M |